Trials / Completed
CompletedNCT03448016
[C-11]NOP-1A and Alcohol Use Disorder
Linking Nociceptive Opioid Peptide (NOP) Receptors With Relapse in Alcoholism
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Rajesh Narendran · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to compare \[C-11\]NOP-1A binding in recently abstinent alcohol use disorders and controls
Detailed description
This will allow for understanding brain stress and antistress mechanisms that underlie abuse of alcohol in humans
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | [C-11] | Radiolabel |
| DRUG | NOP-1A | Tracer |
Timeline
- Start date
- 2016-05-27
- Primary completion
- 2021-03-30
- Completion
- 2021-03-30
- First posted
- 2018-02-27
- Last updated
- 2022-07-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03448016. Inclusion in this directory is not an endorsement.